• KR
  • EN
최근 검색어
닫기

교수찾아삼만리

총 게시물 1,228건, 최근 0 건
이전글  다음글  목록 글쓰기
Dr. 서호경
Dr. Seo Ho Kyung
180cm 큰키 숙여 경청하는 의사
소속병원
국립암센터
진료과목
비뇨의학과
예약전화
031-920-0114
전문분야
방광암
요관암
신우암
전립선요도암
조회수
813
추천의견
0
요일
오전
오후
월요일
화요일
진료가능
수요일
진료가능
목요일
금요일
진료가능
진료가능
토요일
학력
1988-03 1994-02 부산대학교 의학과 대졸(의대)
1995-03 1997-02 부산대학교 대학원 의학과 대학원졸(석사)
2002-03 2006-08 부산대학교 대학원 의학과 대학원졸(박사)
경력
1994-03 1995-02 부산대학교병원 수련의
1995-03 1999-02 부산대학교병원 전공의
2001-04 2002-04 대한적십자 통영병원 비뇨기과장
2002-05 2002-11 부산대학교병원 전임의
2002-12 2003-05 이화여자대학교병원 조교수
2003-06 2009-07 국립암센터 특수암센터 의사직
2007-09 2008-08 Memorial Sloan-Kettering Cancer Center 미국연수
2009-08 2019-01 국립암센터 전립선암센터 의사직
2009-08 2019-01 국립암센터 전립선암센터 비뇨기클리닉 의사직
2012-01 2019-01 국립암센터 비뇨기과 의사직
2014-09 2017-02 국립암센터 비뇨생식기암연구과 선임연구원
2017-03 2019-01 국립암센터 생체표지자연구과 과장
2017-12 2019-01 국립암센터 비뇨기과 과장
2017-12 2019-01 국립암센터 전립선암센터 센터장
2019-02 현재 국립암센터 비뇨기암센터 센터장
2019-02 현재 국립암센터 비뇨의학과 센터장
2019-02 현재 국립암센터 종양면역학연구부 책임연구원
학회
2011-01  2011-12 대한비뇨기종양학회 보험위원회 위원
2011-01  2011-12 대한비뇨기과학회 연구기획위원회 위원
2011-01  2011-12 대한비뇨기종양학회 홍보위원회 위원
2006-11  2008-10 대한비뇨기과 학회 윤리협력위원회 위원
논문
2020 SCI-E  Survival prognoses of Heng intermediate-risk patients with metastaticrenal cell carcinoma treated with immunotherapy or targeted therapy: A real-world, single-center retrospective study: investigative and clinical urology. : (1.8)
2019 SCI-E  Significant clinicopathologic prognostic factors for bladder recurrence, progression, and cancerspecific survival after surgery among patients with upper urinary tract urothelial carcinoma: investigative and clinical urology. 60(6):432~442 (1.638)
2019 SCI-E  Survival of patients receiving systematic therapy for metachronous or synchronous metastatic renal cell carcinoma: a retrospective analysis: BMC cancer. 19(1):688~688 (2.933)
2019 SCI-E  Developing a Prediction Model for Disease-free Survival from Upper Urinary Tract Urothelial Carcinoma in the Korean Population: cancer medicine. Online:Published (3.357)
2019 SCI-E  Identification of Significant Prognostic Tissue Markers Associated with Survival in Upper Urinary Tract Urothelial Carcinoma Patients Treated with Radical Nephroureterectomy: A Retrospective Immunohistochemical Analysis Using Tissue Microarray: cancer research and treatment. Online:Published (3.363)
2019 SCI-E  Use of docetaxel plus androgen deprivation therapy for metastatic hormone-sensitive prostate cancer in Korean patients: A retrospective study: invesitgative and clinical urology. 60(3):195~201 (1.638)
2019 SCI-E  Correlation analyses of computed tomography and magnetic resonance imaging for calculation of prostate volume in colorectal cancer patients with voiding problems who cannot have transrectal ultrasonography: BIOMED RESEARCH INTERNATIONAL. 2019:7029450~7029450 (2.197)
2019 SCI-E  Single-Center Analysis of Human Papillomavirus Infection and P16INK4A Expression among Korean Patients with Penile Cancer: BIOMED RESEARCH INTERNATIONAL. 2019:6940582~6940582 (2.197)
2019 SCI-E  Liver metastasis and Heng risk are prognostic factors in patients with non-nephrectomized synchronous metastatic renal cell carcinoma treated with systemic therapy: PLOS ONE. 14(2):e0211105~e0211105 (2.776)
2018 SCI-E  The Comparison of Oncologic Outcomes between Open and Laparoscopic Radical Nephroureterectomy for the Treatment of Upper Tract Urothelial Carcinoma: A Korean Multicenter Collaborative Study: CANCER RESEARCH AND TREATMENT. 51(1):240~251 (3.23)
2018  기타  Prostatectomy Provides Better Symptom-Free Survival Than Radiotherapy Among Patients With High-Risk or Locally Advanced Prostate Cancer After Neoadjuvant Hormonal Therapy: Korean Journal of Urological Oncology. 16(3):126~134 (0)
2018 SCI-E  Effect of Neoadjuvant Hormone Therapy on Resection Margin and Survival Prognoses in Locally Advanced Prostate Cancer after Prostatectomy Using Propensity-Score Matching: Biomed Research International. 2018:7~7 (2.583)
2018  기타  Clear cell papillary renal cell carcinoma: A case report and review of the literature: World Journal of Nephrology. 7(8):155~160 (0)
2018  기타  The Effect of the First Computed Tomography Examination on Renal Function During the Initial Cancer Work-up in Newly Diagnosed Cancer Patients without Chronic/Kidney Disease: A Retrospective, Single-institution, Observational Study: journal of cancer science and therapy. 10(11):332~337 (0)
2018 SCI-E  Oncologic, Perioperative Outcomes of Female Radical Cystectomy: Results from a Multicenter Study in Korea.: CANCER RESEARCH AND TREATMENT. Online:Published (3.23)
2018 SCI-E  Laparoscopy Versus Open Nephroureterectomy in Prognostic Outcome of Patients with Advanced Upper Tract Urothelial Cancer: A Retrospective, Multicenter, Propensity-Score Matching Analysis: CANCER RESEARCH AND TREATMENT. Online:Published (3.23)
2018 SCI-E  Retrospective Study of the Significant Predictive Role of Inflammatory Degree in Initial and Repeat Prostate Biopsy Specimens for Detecting Prostate Cancer: CANCER RESEARCH AND TREATMENT. Online:Published (3.23)
2018  기타  A Surgically Treated Case of Ureterovesical Amyloidosis of the Bladder in a Patient with Idiopathic Thrombocytopenia: Case Reports in Urology. 2018:1059349~1059349 (0)
2018 SCI-E  Immune checkpoint inhibitors for urothelial carcinoma: Investigative and clinical urology. 59(5):285~296 (0)
2018 SCI-E  The neutrophil-to-lymphocyte ratio makes the Heng risk model improve better the prediction of overall survival in metastatic renal cell cancer patients: Japanese Journal of clinical Oncology. 48(9):835~840 (2.37)
2018 SCI-E  Retrospective analysis of 25 immunohistochemical tissue markers for differentiating multilocular cystic renal neoplasm of low malignant potential and multicystic renal cell carcinoma: Histology and histopathology. 33(6):589~596 (2.025)
2018 SCI-E  Risk of second primary Cancer among bladder Cancer patients: a population-based cohort study in Korea.: BMC Cancer. 18(1):617~617 (3.288)
2018  기타  Prostate stem cell antigen mRNA in blood is a predictor of survival after radical prostatectomy in patients with high-risk prostate cancer.: Oncotarget. 9(41):26291~26298 (0)
2018 SCI  Prognostic significance of nephrectomy in metastatic renal cell carcinoma treated with systemic cytokine or targeted therapy: A 16-year retrospective analysis: Scientific reports. 8(1):2974~2974 (4.122)
2017 SCI  Electrostatic interaction of tumor-targeting adenoviruses with aminoclay acquires enhanced infectivity to tumor cells inside the bladder and has better cytotoxic activity: Drug Delivery. 25(1):49~58 (6.402)
2017 SCI-E  Lifestyle Risk Prediction Model for Prostate Cancer in a Korean Population: Cancer Research and Treatment. 50(4):1194~1202 (3.772)
2017 SCI-E  Second Primary Cancer Risk Among Kidney Cancer Patients in Korea: A Population-Based Cohort Study: Cancer Research and Treatment. 50(1):293~301 (3.772)
2017 SCI-E  Hand-Holding during Cystoscopy Decreases Patient Anxiety, Pain, and Dissatisfaction: A Pilot Randomized Controlled Trial.: Urologia internationalis. 100(2):222~227 (1.611)
2017  기타  The retrospective analysis of prognostic significance of smoking status in bladder cancer: Korean Journal of Urological Oncology. 15:1~10 (0)
2017 SCI-E  Recommended oral sodium bicarbonate administration for urine alkalinization did not affect the concentration of mitomycin-C in non-muscle invasive bladder cancer patients: oncotarget. Online:Published (5.168)
2017 SCI-E  A retrospective comparative study of progression-free survival and overall survival between metachronous and synchronous metastatic renal cell carcinoma in intermediate or poor risk patients treated with VEGF-targeted therapy: Oncotarget. 8(55):93633~93643 (5.168)
2017 SCI-E  Establishment and Application of Prostate Cancer CirculatingTumor Cells in the Era of Precision Medicine: BioMed Research International. 2017:1~9 (2.476)
2017  기타  Renal myxofibrosarcoma in a woman: A cese report and literature review: Journal of Cytology and Histology. 8:4~8 (0)
2017 SCI-E  Survival outcomes of double- and triple-sequential targeted therapy in patients with metastatic renal cell carcinoma: a retrospective comparison: Oncotarget. Online:Published (5.168)
2017 SCI-E  Retrograde pyelography predicts retrograde ureteral stenting failure and reduces unnecessary stenting trials in patients with advanced non-urological malignant ureteral obstruction: PLOS one. 12(9):e0184965~e0184965 (2.806)
2017 SCI-E  The effect of predisposing atheroembolic risk factors on renal functional recovery between laparoscopy and open technique in patients with T1-stage renal cell carcinoma who underwent partial nephrectomy: A retrospective comparison study: Japanese Journal of Clinical Oncology. 47(9):876~882 (1.905)
2017 SCI-E  Effect of renal embolization in patients with synchronous metastatic renal cell carcinoma: A retrospective comparison of cytoreductive nephrectomy and systemic medical therapy: Oncotarget. 8(30):49615~49624 (5.168)
2017 SCI-E  The prognostic value of BAP1, PBRM1, pS6, PTEN, TGase2, PD-L1, CA9, PSMA, and Ki-67 tissue markers in localized renal cell carcinoma: A retrospective study of tissue microarrays using immunohistochemistry: PLOS ONE. Online:Published (2.806)
2017 SCI-E  Establishment and application of bladder cancer patient-derived xenografts as a novel preclinical platform: Translational Cancer Research. 6(S4):s733~s743 (1.167)
2017 SCI-E  Initial computed tomography imaging details during first-line systemic therapy is of significant prognostic value in patients with naive, unresectable metastatic renal cell carcinoma: PLOS ONE. 12(5):e0177975~e0177975 (2.806)
2016 SCI-E  Evaluation of the efficacy of solifenacin for preventing catheter-related bladder discomfort after transurethral resection of bladder tumors in patients with non-muscle invasive bladder cancer: a prospective, randomized, multicenter study .: clinical Genitourinary cancer. 15(1):157~162 (2.599)
2016 SCI-E  Pretreatment prognostic nutritional index is an independent predictor of survival in patients with metastatic renal cell carcinoma treated with targeted therapy: Clinical Genitourinary Cancer. 15(1):100~111 (2.599)
2016 SCI  Prostate Cancer in a Patient With a Family History of BRCA Mutation: a Case Report And Literature Review: Journal of Korean Medical science. 32(2):377~381 (1.256)
2016 SCI-E  Baseline Chronic Kidney Disease and Ischemic Method of Partial Nephrectomy Are Important Factors for the Short- and Long-Term Deterioration in Renal Function for Renal Cell Carcinoma Staged T1-T2: A Retrospective Single Center Study: BioMed Research International. 2016:5398381~5398389 (2.134)
2016 SCI-E  Bladder chondrosarcoma plus urothelial carcinoma in recurred transitional cell carcinoma of the upper urinary tract: a case report and literature review: World Journal of Surgical Oncology. 14(1):270~270 (1.286)
2016 SCI-E  Current Trends in the Incidence and Survival Rate of Urological Cancers in Korea: Cancer Research and Treatment. Online:Published (4.245)
2016 SCI-E  A retrospective study of predictive factors for unexpectedly prolonged or shortened progression-free survival and overall survival among patients with metastatic renal cell carcinoma who received first-line targeted therapy: BMC cancer. 16(1):577~577 (3.265)
2016 SCI-E  The establishment of a growth-controllable orthotopic bladder cancer model through the down-regulation of c-myc expression: Oncotarget. Online:Published (5.008)
2016 SCI-E  Systemic treatments for metastatic renal cell carcinoma: 10-year experience of immunotherapy and targeted therapy: cancer research and treatment. 48(3):1092~1101 (4.245)
2016 SCI-E  PSCA, Cox-2, and Ki-67 are independent, predictive markers of biochemical recurrence in clinically localized prostate cancer: A retrospective study: Asian Journal of Andrology. Online:Published (2.644)
2016 SCI-E  Prostate Stem Cell Antigen Expression in Radical Prostatectomy Specimens Predicts Early Biochemical Recurrence in Patients with High Risk Prostate Cancer Receiving Neoadjuvant Hormonal Therapy: PloS one. 11(3):e0151646~e0151646 (3.057)
2015 SCI-E  A case report of partial nephrectomy of mucinous cystadenocarcinoma in kidney and its literature review: Cancer research and treatment. 48(2):838~842 (3.318)
2015 SCI  Overexpression of BRCA1 or BRCA2 in prostatectomy specimens is predictive of biochemical recurrence after radical prostatectomy: Histopathology. 68(5):673~679 (3.453)
2015 SCI-E  Risk of Second Primary Cancer among Prostate Cancer Patients in Korea: A Population-Based Cohort Study: PLOS ONE. 10(10):e0140693~e0140693 (3.234)
2015 SCI-E  The quantified level of circulating prostate stem cell antigen mRNA relative to GAPDH level is a clinically significant indictor for predicting biochemical recurrence in prostate cancer patients after radical prostatectomy: BioMed Research International. 2015:292454~292454 (1.579)
2015 SCI-E  Outcomes of pelvic exenteration for recurrent or primary locally advanced colorectal cancer: Annals of Surgical Treatment and Research. 89(3):131~137 (0)
2015 SCI-E  Outcomes of pelvic exenteration for recurrent or primary locally advanced colorectal cancer: Annals of Surgical Treatment and Research. 89:Issue3~ ()
2015 SCI-E  The prevalence and outcomes of pT0 disease after neoadjuvant hormonal therapy and radical prostatectomy in high-risk prostate cancer.: BMC urology. 15:82~82 (1.413)
2015 SCI  Trends in the Use of Chemotherapy Before and After Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer in Korea: Journal of Korean medical science. 30(8):1150~1156 (1.266)
2015  기타  Oncologic aspects of long-term followed incidental prostate cancer detected by cystoprostatectomy in Korean patients.: Prostate international. 3(2):56~61 (0)
2015 SCI-E  Changes in urination according to the sound of running water using a mobile phone application: PloS one [electronic resource]. 10(5):0126798~0126798 (3.234)
2015 SCI-E  Overexpression of ERG and wild-type PTEN are associated with favorable clinical prognosis and low biochemical recurrence in prostate cancer: PloS one [electronic resource]. 10(4):0122498~0122498 (3.234)
2015 SCI  P70S6K and Elf4E Dual Inhibition Is Essential to Control Bladder Tumor Growth and Progression in Orthotopic Mouse Non-muscle Invasive Bladder Tumor Model: Journal of Korean medical science. 30(3):308~316 (1.266)
2014  기타  Predictive factors for maximal size reduction of renal target lesion in patients with metastatic renal cell carcinoma receiving targeted therapies: The Korean Journal of urological Oncology (대한비뇨기 종양 학술지). 12(3):1~8 (0)
2014  기타  Experience of successful treatment for an intractable advanced ureter cancer with extraureteral extension using omental flap transposition: A case report: Journal of Clinical Case Reports. :~ (0)
2014 SCI-E  Development of Replication-competent Adenovirus for Bladder Cancer by Controlling Adenovirus E1a and E4 Gene Expression with the Survivin Promoter: Oncotarget [electronic resource]. 5(14):5615~5623 (6.627)
2014 SCI  Pelvic Floor Musculature and Bladder Neck Changes Before and After Continence Recovery After Radical Prostatectomy in Pelvic MRI: Journal of magnetic resonance imaging : JMRI. 39(6):1431~1435 (2.788)
2014 SCI-E  Treatment outcome of docetaxel plus prednisolone for metastatic castration-resistant prostate cancer in Korea: Journal of Cancer Research and Therapeutics. 10(2):251~257 (0.949)
2014 SCI-E  Detection of Human Papillomavirus Infection and p16 Immunohistochemistry Expression in Bladder Cancer with Squamous Differentiation: PLOS one. 9(3):e93525~e93525 (3.534)
2014 SCI  Establishment of an Orthotopic Mouse Non-Muscle Invasive Bladder Cancer Model Expressing the Mammalian Target of Rapamycin Signaling Pathway: J of Korean Med Sci. 29(3):343~350 (1.253)
2014 SCI  Intravesical instillation of c-MYC inhibitor KSI-3716 suppresses orthotopic bladder tumor growth: The Journal of Urology. 191(2):510~518 (3.753)
2014 SCI-E  Antitumor activity of the c-Myc inhibitor KSI-3716 in gemcitabine-resistant bladder cancer: Oncotarget. 5(2):326~337 (6.627)
2013 SCI-E  Genetic variations of α -methylacyl-CoA racemase are associated with sporadic prostate cancer risk in ethnically homogenous Koreans: Biomed Research International. 2013:1~11 (0)
2013 SCI  Validation of the MSKCC and Heng Risk Criteria Models for Predicting Survival in Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib: Annals of Surgical Oncology. 20(13):4397~4404 (4.12)
2013 SCI  Overestimation of Nuclear Matrix Protein 22 in Concentrated Urine: Urology. 82(5):1059~1064 (2.424)
2012 SCI-E  Urologic complications of laparoscopic radical hysterectomy and lymphadenectomy: International urogynecology journal. 23(11):1605~1611 (1.832)
2012 SCI  Association of common variations of 8q24 with the risk of prostate cancer in Koreans and a review of the Asian population: British Journal of Urology International. 110(6ptB):E318~E325 (2.844)
2012 SCI  Adjuvant Intravesical Instillation for Primary T1G3 Bladder Cancer: BCG versus MMC in Korea: Anticancer research. 32(4):1493~1498 (1.725)
2011 SCI  Prostate Volume has Prognostic Value Only in Pathologic T2 Radical Prostatectomy Specimens: Journal of Korean Medical Science. 26:807~813 (0.834)
2011 SCI  Haplotype Analysis of Prostate Stem Cell Antigen and Association With Prostate Cancer Risk.: The Journal of Urology. 185(6):2112~2118 (3.862)
2011 SCI-E  Paclitaxel and cisplatin chemotherapy for metastatic urothelial carcinoma after failure of two courses of platinum-based regimens: International journal of urology. 18(5):350~357 (1.46)
2011 SCI  Renal safety and efficacy of cisplatin-based chemotherapy in patients with a solitary kidney after nephroureterectomy for urothelial carcinoma of the upper urinary tract.: Cancer Chemotherapy and Pharmacology. 67:769~774 (2.759)
2011 SCI  A prospective evaluation of conventional cystography for detection of urine leakage at the vesicourethral anastomosis site after radical prostatectomy based on computed tomography: Clinical Radiology. 66(3):251~256 (1.765)
상세정보 펼쳐보기
저서
2017 Bladder cancer
2017 방광암 100문 100답
2014 신장암 100문100답
2011 전립선암 100문 100답
2006 암과음식
상세정보 펼쳐보기
동병원
동일과
LIST
전립선암,로봇수술,개복수술,유전자연구
월요일오후
목요일오전
목요일오후
타병원
동일과
LIST
메디플렉스 세종병원
전립선비대증,정계정맥류,정관복원술,정관절제술
명지병원
남성과학,성기능장애,불임증,전립선질환
고려대학교 구로병원
성기능장애,불임,남성갱년기,비뇨기종양,결석
전남대학교병원
남성의학,전립선질환
이윤수앤조성완 비뇨기과의원
왜소음경,발기부전,정관복원수술,전립선비대증
최형기성공비뇨기과
발기부전,왜소음경,전립선비대증
고려대학교 안암병원
방광암,전립선암,신장암,종양학,복강경수술
칠곡경북대학교병원
비뇨기종양,전립선,로봇수술,복강경수술
서울대학교병원
전립선비대증,성의학,성기능장애,불임,무정자증
충북대학교병원
종양,전립선,선천성요로질환
가톨릭대학교 부천성모병원
배뇨장애,요실금클리닉,소아비뇨기,전립선질환
서울아산병원
전립선암,전립선비대증,신장암,비뇨기종양,로봇수술
화순전남대학교병원
비뇨기종양,전립선질환,여성요실금,배뇨장애
이대목동병원
배뇨장애,요실금,전립선,요로생식,결석
이대서울병원
신경성배뇨장애,노인성배뇨장애,요실금,여성성기능
삼성서울병원
전립선비대증,과민성방광,요실금,야간빈뇨
서울아산병원
배뇨장애,여성요실금,전립선비대증
계명대학교 동산병원
비뇨기종양,전립선암,전립선질환,로봇수술
중앙대학교병원
비뇨기종양,남성과학,복강경수술,여성비뇨
분당서울대학교병원
전립선암,신장암,비뇨기종양,복강경수술,로봇수술
한림대학교 강남성심병원
비뇨기종양,전립선비대증,요로결석,다빈치로봇수술
고려대학교 안산병원
배뇨장애,비뇨기계복강경수술,요실금
서울대학교병원
방광암,전립선암,로봇수술
삼성서울병원
전립선암,로봇수술,하이푸,PSA
순천향대학교 서울병원
전립선질환,비뇨기계종양,배뇨장애,남성학
강남세브란스병원
로봇수술,전립선암,신장암,방광암,전립선비대증
신촌세브란스병원
비뇨기종양,전립선,로봇수술,배뇨장애,남성학
서울아산병원
전립선암,비뇨기암,전립선질환,로봇수술
강동경희대학교병원
전립선비대증,전립선암,요성요실금,남성갱년기
건양대학교병원
전립선질환,남성의학,요로결석,성기능장애
고려대학교 안암병원
종양학,전립선암,로봇수술,복강경수술
고신대학교복음병원
전립선암,여성비뇨기질환,전립선비대증
부산대학교병원
전립선암,비뇨기종양,로봇수술,복강경수술
서울대학교병원
전립선비대증,전립선암,신장암,신우요관암
신촌세브란스병원
전립선암,신장암,로봇수술,복강경수술,외국인진료
분당서울대학교병원
전립선적출술,부분신적출술,복강경신장적출술
가톨릭대학교 서울성모병원
비뇨기종양,로봇수술,복강경수술,전립선질환
경희의료원
비뇨기종양,신이식,요로결석,로봇수술
이대목동병원
비뇨기종양,인공방광,복강경수술,로봇수술,전립선질환
서울대학교병원
방광암,전립선암,인공방광,로봇수술,요관암
서울아산병원
전립선암,신장암,로봇수술
인제대학교 부산백병원
비뇨기종양,전립선질환,로봇수술
가톨릭대학교 서울성모병원
전립선,레이저수술,요실금,성기능,소아비뇨
가톨릭대학교 서울성모병원
비뇨기종양,로봇및복강경수술
가톨릭대학교 서울성모병원
비뇨기종양,로봇및복강경수술
서울아산병원
소아비뇨기질환,성인일반비뇨기질환
서울아산병원
전립선비대증,배뇨장애,남성의학
서울아산병원
요로결석,전립선비대증
서울아산병원
수신증,방광요관역류,복강경로봇수술,전립선질환
서울아산병원
신장암,비뇨기종양,로봇수술,복강경수술
서울아산병원
전립선암,신장암,방광암,로봇수술,복강경수술
서울아산병원
전립선암,방광암,신장암,로봇수술,복강경수술
서울아산병원
방광암,신우요관암,신장암
강남세브란스병원
방광암,전립선암,신장암,인조방광,전립질환
강남세브란스병원
비뇨기암,배뇨장애,복강경수술,로봇수술
아주대학교병원
비뇨기종양,비뇨기암
용인세브란스병원
소아비뇨의학과,요도하열,잠복고환
순천향대학교 부천병원
로봇수술,여성비뇨기과,배뇨장애,남성의학
순천향대학교 부천병원
소아비뇨기질환,야뇨증,전립선질환
순천향대학교 부천병원
로봇수술,비뇨기계종양
보라매서울대학교병원
전립선비대증,요로결석,성기능장애,배뇨장애
동국대학교 일산병원
요로결석,내비뇨기,배뇨장애,소아비뇨기과,요실금

자동등록방지
자동등록방지 숫자를 순서대로 입력하세요.
hi
이전글  다음글  목록 글쓰기

본 컨텐츠는 광고영역으로 성예사의 추천 또는 보증의 의미를 가지지 않습니다.